speb/financial-data huggingface dataset:
Financial ratios for 9240.T — annual report dated 2025-07-31
Total revenue: 18365904.978891645
Gross profit: 7071212.222743417
Operating income: 347048.1806607251
Net income: 234691.4159351337
Capital expenditures: 57361.12041814649
Operating cash flow: -445513.6366682303
Depreciation & amortization: 136152.248207465
Net tangible assets: 7364223.0114588225
Owner earnings: 313482.5437244522
Return on net tangible assets (%): 4.256831212697788
Capex to operating income (%): 16.52828731415331
Buffett classification: The Great
Stock price: 3.5448636333176977
P/E ratio: 73.08090517659824
Shares outstanding: 4838398
Book value: 7455752.864705489
P/B ratio: 2.300433158790676
Market cap (USD): 17151461.113717083
Debt to equity: 0.02657775956254685
Current ratio: 3.8119005224904403
Quick ratio: 3.8080095741265065
Effective tax rate (%): 41.76228008912833
Interest coverage ratio: 109.9575371549894
COGS to revenue (%): 61.49811875899391
Free cash flow (dilution-adjusted): -559257.5219459895
Buyback yield (%): 0
Retained earnings: 5285981.371037995
Inventory turnover: 1264.4456114028508
Receivables turnover: 7.879346479261957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.53604310598523
FCF margin (%): -3.045085568006352
Revenue growth (%): 3.70591362388508
Rule of 40 score: 0.6608280558787278
Financial ratios for 9240.T — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 7364223.0114588225
Buffett classification: The Gruesome
Stock price: 3.5448636333176977
Shares outstanding: 4838398
Book value: 7455752.864705489
P/B ratio: 2.300433158790676
Market cap (USD): 17151461.113717083
Debt to equity: 0.02657775956254685
Current ratio: 3.8119005224904403
Quick ratio: 3.8080095741265065
Buyback yield (%): 0
Retained earnings: 5285981.371037995
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9240.T — quarterly report dated 2025-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.9246263807667314
Shares outstanding: 4838398
Market cap (USD): 18988904.431448992
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9262.T — annual report dated 2021-07-31
Total revenue: 91856960.05849557
Gross profit: 24865423.635865096
Operating income: 7675824.8788958965
Net income: 4991399.323645005
Capital expenditures: 23532035.462937575
Operating cash flow: 3376281.8755141213
Depreciation & amortization: 3073658.71492551
Net tangible assets: 42455863.26661183
Owner earnings: -15466977.424367059
Return on net tangible assets (%): -36.43072177625608
Capex to operating income (%): 306.5733759460451
Buffett classification: The Gruesome
Stock price: 16.342473265697834
P/E ratio: 35.779580111864114
Shares outstanding: 10927977
Book value: 45026368.704871595
P/B ratio: 3.966346323445319
Market cap (USD): 178590171.9706608
Debt to equity: 0.3918227241955733
Current ratio: 2.3795959363936174
Quick ratio: 2.2349599695821616
Effective tax rate (%): 36.97573934860232
Interest coverage ratio: 524.227215980025
COGS to revenue (%): 72.93027809756549
SG&A to revenue (%): 9.704380168496339
Free cash flow (dilution-adjusted): -21331980.62334339
Buyback yield (%): 0.0012078066862360598
Retained earnings: 31889041.221094966
Inventory turnover: 36.15029198232323
Receivables turnover: 10.385361392558758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.241240233603486
FCF margin (%): -23.223042227566577
Rule of 40 score: -23.223042227566577
Financial ratios for 9262.T — annual report dated 2022-07-31
Total revenue: 83451741.07142857
Gross profit: 22982648.80952381
Operating income: 4178311.0119047617
Net income: 2990260.4166666665
Capital expenditures: 10076056.547619047
Operating cash flow: 9002090.773809524
Depreciation & amortization: 4539784.226190476
Net tangible assets: 37018087.797619045
Owner earnings: -2546011.904761905
Return on net tangible assets (%): -6.877751002918258
Capex to operating income (%): 241.15142503539215
Buffett classification: The Gruesome
Stock price: 9.49970238095238
P/E ratio: 34.71688570911018
Shares outstanding: 10927977
Book value: 39467090.77380952
P/B ratio: 2.630356762824362
Market cap (USD): 103812529.12589285
Debt to equity: 0.41368326572564507
Current ratio: 2.2966592943460005
Quick ratio: 2.0722605837087578
Effective tax rate (%): 34.92628664416001
Interest coverage ratio: 110.69682633550168
COGS to revenue (%): 72.45995288480279
SG&A to revenue (%): 10.840150878474995
Free cash flow (dilution-adjusted): -2454508.9285714286
Buyback yield (%): 0
Retained earnings: 28750044.64285714
Inventory turnover: 25.73112127784198
Receivables turnover: 11.005283871974285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.535754121573676
FCF margin (%): -2.9412315394001776
Revenue growth (%): -9.150334369561609
Rule of 40 score: -12.091565908961787
Financial ratios for 9262.T — annual report dated 2023-07-31
Total revenue: 87146618.35748793
Gross profit: 26331443.59192953
Operating income: 4760983.23387326
Net income: 4280839.727195227
Capital expenditures: 5594124.751349816
Operating cash flow: 8535294.11764706
Depreciation & amortization: 4900007.104290992
Net tangible assets: 39190927.820403524
Owner earnings: 3586722.0801364016
Return on net tangible assets (%): 9.151919282373019
Capex to operating income (%): 117.4993583583524
Buffett classification: The Gruesome
Stock price: 8.642512077294686
P/E ratio: 22.06230067500759
Shares outstanding: 10927977
Book value: 42030363.73969878
P/B ratio: 2.2470700893243185
Market cap (USD): 94445173.20289855
Debt to equity: 0.33031574015321336
Current ratio: 2.042173527569316
Quick ratio: 1.7763344215082082
Effective tax rate (%): 29.649468552108043
Interest coverage ratio: 150.39407540394976
COGS to revenue (%): 69.78488529732142
SG&A to revenue (%): 10.782311023010317
Free cash flow (dilution-adjusted): 1723586.24609264
Buyback yield (%): 0.0002707967670871672
Retained earnings: 31731869.84938903
Inventory turnover: 18.371490563527185
Receivables turnover: 10.769903027695712
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.58105577476259
FCF margin (%): 1.9778004913767762
Revenue growth (%): 4.427561652544577
Rule of 40 score: 6.405362143921353
Financial ratios for 9262.T — annual report dated 2024-07-31
Total revenue: 88788157.46381085
Gross profit: 28592218.510512874
Operating income: 5033156.481299535
Net income: 4375797.471670925
Capital expenditures: 7036274.317154648
Operating cash flow: 8615032.422872864
Depreciation & amortization: 5226075.849872274
Net tangible assets: 39741252.37440231
Owner earnings: 2565599.0043885503
Return on net tangible assets (%): 6.455757811097758
Capex to operating income (%): 139.7984414610912
Buffett classification: The Gruesome
Stock price: 6.082334446846139
P/E ratio: 15.189827996326638
Shares outstanding: 10927977
Book value: 42076465.57935417
P/B ratio: 1.5796861743552972
Market cap (USD): 66467610.94144233
Debt to equity: 0.2668338466836057
Current ratio: 1.971686539957825
Quick ratio: 1.6802356751466097
Effective tax rate (%): 30.114130889614195
Interest coverage ratio: 162.90269238923045
COGS to revenue (%): 67.79725373595899
SG&A to revenue (%): 11.64006253500479
Free cash flow (dilution-adjusted): 996469.5093993582
Buyback yield (%): 0
Retained earnings: 32566948.319905683
Inventory turnover: 17.338723553583353
Receivables turnover: 10.451319320921547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.537826062509518
FCF margin (%): 1.1223000204790927
Revenue growth (%): 1.8836520994871944
Rule of 40 score: 3.0059521199662873
Financial ratios for 9262.T — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 40596404.93186243
Buffett classification: The Gruesome
Stock price: 4.3622972096041535
Shares outstanding: 10927977
Book value: 42675184.94484101
P/B ratio: 1.1170680018220123
Market cap (USD): 47671083.57371837
Debt to equity: 0.2821253949441672
Current ratio: 2.143856195204634
Quick ratio: 1.8256613097276586
Buyback yield (%): 0
Retained earnings: 33253913.04347826
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9262.T — annual report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.885076727199625
Shares outstanding: 10927977
Market cap (USD): 53384006.11807277
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9262.T — quarterly report dated 2025-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.432098765432099
Shares outstanding: 10927977
Market cap (USD): 59361850.37037037
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 93M1.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.93181818181818
Shares outstanding: 4281384
Market cap (USD): 76772999.45454545
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 93M1.DE — annual report dated 2022-12-31
Total revenue: 7027042.55319149
Operating income: 31251227.65957447
Net income: 30973296.80851064
Capital expenditures: 5973.404255319149
Operating cash flow: 4021.276595744681
Depreciation & amortization: 26775.531914893618
Net tangible assets: 235554939.36170214
Owner earnings: 30994098.936170213
Return on net tangible assets (%): 13.157906609879142
Capex to operating income (%): 0.019114142715891264
Buffett classification: The Great
Stock price: 12.063829787234043
P/E ratio: 1.6675618404171693
Shares outstanding: 4281384
Book value: 235554943.6170213
P/B ratio: 0.21926896135859744
Market cap (USD): 51649887.82978724
Debt to equity: 0.0509991148245772
Current ratio: 0.2882069236212696
Quick ratio: 0.2882069236212696
Effective tax rate (%): 1.2175576247332416
Interest coverage ratio: 173.35768999256436
COGS to revenue (%): 0
SG&A to revenue (%): 14.945998891819142
Free cash flow (dilution-adjusted): -1952.1276595744682
Buyback yield (%): 0
Retained earnings: 187148542.5531915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.158277617364828
FCF margin (%): -0.02778021685222136
Rule of 40 score: -0.02778021685222136
Financial ratios for 93M1.DE — annual report dated 2023-12-31
Total revenue: 6941983.333333333
Operating income: 33565467.777777776
Net income: 32827240
Capital expenditures: 5220
Operating cash flow: -2240340
Depreciation & amortization: 21232.222222222223
Net tangible assets: 278851288.8888889
Owner earnings: 32843252.222222224
Return on net tangible assets (%): 11.77805286577282
Capex to operating income (%): 0.015551697460495197
Buffett classification: The Great
Stock price: 13.71111111111111
P/E ratio: 1.7882262332542525
Shares outstanding: 4281384
Book value: 278851293.3333333
P/B ratio: 0.21051554407947998
Market cap (USD): 58702531.73333333
Debt to equity: 0.052016773065870346
Current ratio: 1.41735370378841
Quick ratio: 1.41735370378841
Effective tax rate (%): 0.7508591767168216
Interest coverage ratio: 52.42274440526433
COGS to revenue (%): 0
SG&A to revenue (%): 18.28343965101232
Free cash flow (dilution-adjusted): -2245560
Buyback yield (%): 0
Retained earnings: 228293495.55555555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.558964827538045
FCF margin (%): -32.34752796391041
Revenue growth (%): -1.2104554542582777
Rule of 40 score: -33.55798341816869
Financial ratios for 93M1.DE — annual report dated 2024-12-31
Total revenue: 6366261.458333334
Operating income: 34331197.91666667
Net income: 33376988.541666668
Capital expenditures: 4321.875
Operating cash flow: 1905788.5416666667
Depreciation & amortization: 28811.458333333336
Net tangible assets: 289448341.6666667
Owner earnings: 33401478.125
Return on net tangible assets (%): 11.53970270918521
Capex to operating income (%): 0.012588768415511278
Buffett classification: The Great
Stock price: 18.322916666666668
P/E ratio: 2.3503451233195873
Shares outstanding: 4281384
Book value: 289448345.8333333
P/B ratio: 0.27102397847238235
Market cap (USD): 78447442.25
Debt to equity: 0.03799693146170598
Current ratio: 0.521488941647315
Quick ratio: 0.521488941647315
Effective tax rate (%): 0.880005659773319
Interest coverage ratio: 34.15105112199813
COGS to revenue (%): 0
SG&A to revenue (%): 18.6396516401322
Free cash flow (dilution-adjusted): 1901466.6666666667
Buyback yield (%): 0
Retained earnings: 242050411.45833334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.552594704333451
FCF margin (%): 29.867869535544717
Revenue growth (%): -8.29333415762545
Rule of 40 score: 21.57453537791927
Financial ratios for 93M1.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 289448341.6666667
Buffett classification: The Gruesome
Stock price: 18.322916666666668
Shares outstanding: 4281384
Book value: 289448345.8333333
P/B ratio: 0.27102397847238235
Market cap (USD): 78447442.25
Debt to equity: 0.03799693146170598
Current ratio: 0.521488941647315
Quick ratio: 0.521488941647315
Buyback yield (%): 0
Retained earnings: 242050411.45833334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 93M1.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 241318332.94117647
Buffett classification: The Gruesome
Stock price: 16.847058823529412
Shares outstanding: 4281384
Book value: 241318337.6470588
P/B ratio: 0.2988945174966762
Market cap (USD): 72128728.09411766
Debt to equity: 0.024885590835404547
Current ratio: 0.40246840499831676
Quick ratio: 0.4020002279437035
Buyback yield (%): 0
Retained earnings: 187786552.94117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9761.T — annual report dated 2022-03-31
Total revenue: 134572684.80576956
Gross profit: 22854581.216194067
Operating income: 4628167.5135223735
Net income: 3651762.0062284875
Capital expenditures: 16992894.607441403
Operating cash flow: 19846287.49385347
Depreciation & amortization: 14356269.464022292
Net tangible assets: 124443714.1452221
Owner earnings: 1015136.8628093749
Return on net tangible assets (%): 0.8157397661924013
Capex to operating income (%): 367.1624797026538
Buffett classification: The Gruesome
Stock price: 10.654237010326176
P/E ratio: 10.105688915275993
Shares outstanding: 3463746
Book value: 127245418.78380594
P/B ratio: 0.2900188563194531
Market cap (USD): 36903570.82756925
Debt to equity: 0.741816403273735
Current ratio: 1.303743687248404
Quick ratio: 1.1661921240053537
Effective tax rate (%): 33.2023631596542
Interest coverage ratio: 12.861056706900479
COGS to revenue (%): 83.01691799895482
Free cash flow (dilution-adjusted): 2853392.8864120636
Buyback yield (%): 0.009216131972057551
Retained earnings: 11904425.504015736
Inventory turnover: 10.720860384184345
Receivables turnover: 2.262646724268954
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.506263005814081
FCF margin (%): 2.1203358545832693
Rule of 40 score: 2.1203358545832693
Financial ratios for 9761.T — annual report dated 2023-03-31
Total revenue: 118138881.38138139
Gross profit: 17257672.672672674
Operating income: 2113596.096096096
Net income: 1174834.834834835
Capital expenditures: 13052717.717717718
Operating cash flow: 18039924.924924925
Depreciation & amortization: 13072072.072072074
Net tangible assets: 113007327.32732734
Owner earnings: 1194189.18918919
Return on net tangible assets (%): 1.056736069626887
Capex to operating income (%): 617.5597003527142
Buffett classification: The Gruesome
Stock price: 8.535135135135137
P/E ratio: 25.163996935739483
Shares outstanding: 3463746
Book value: 115655135.13513514
P/B ratio: 0.2556180505884223
Market cap (USD): 29563540.183783792
Debt to equity: 0.736018285697668
Current ratio: 1.2947570138873488
Quick ratio: 1.1534657249115992
Effective tax rate (%): 46.29550188922711
Interest coverage ratio: 5.611764471376175
COGS to revenue (%): 85.39204030172917
Free cash flow (dilution-adjusted): 4987207.207207208
Buyback yield (%): 0.18700495590717653
Retained earnings: 9946509.00900901
Inventory turnover: 10.70546029323074
Receivables turnover: 2.3683435906728545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2562497679652047
FCF margin (%): 4.22147827107595
Revenue growth (%): -12.211841837076584
Rule of 40 score: -7.990363566000633
Financial ratios for 9761.T — annual report dated 2024-03-31
Total revenue: 113416501.58478606
Gross profit: 21795635.2350766
Operating income: 6595707.871104068
Net income: 4518343.898573693
Capital expenditures: 12530731.642894875
Operating cash flow: 7866712.889593238
Depreciation & amortization: 11500495.245641839
Net tangible assets: 104766323.296355
Owner earnings: 3488107.5013206564
Return on net tangible assets (%): 3.329416735809048
Capex to operating income (%): 189.98312065627206
Buffett classification: The Gruesome
Stock price: 8.371170100369783
P/E ratio: 6.417308554054172
Shares outstanding: 3463746
Book value: 107178750.66032752
P/B ratio: 0.2705350339674022
Market cap (USD): 28995606.950475436
Debt to equity: 0.764429261019706
Current ratio: 1.2400912587813608
Quick ratio: 1.1132298708556636
Effective tax rate (%): 33.40755656033735
Interest coverage ratio: 17.80424940287334
COGS to revenue (%): 80.78265955083883
Free cash flow (dilution-adjusted): -4664018.753301637
Buyback yield (%): 0.004395259324998525
Retained earnings: 11996764.39513999
Inventory turnover: 10.108098972220521
Receivables turnover: 2.0111025284623696
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.209460499648761
FCF margin (%): -4.112292909876952
Revenue growth (%): -3.997312096895797
Rule of 40 score: -8.10960500677275
Financial ratios for 9761.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 113328442.35887378
Buffett classification: The Gruesome
Stock price: 11.306275388709903
Shares outstanding: 3463746
Book value: 116078918.61605266
P/B ratio: 0.33737449159115973
Market cap (USD): 39162066.15254237
Debt to equity: 0.7592114951910697
Current ratio: 1.1145688573384775
Quick ratio: 1.004100988604806
Buyback yield (%): 0
Retained earnings: 14902143.157304944
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9761.T — annual report dated 2025-03-31
Total revenue: 122963447.4000802
Gross profit: 26408488.170030743
Operating income: 10102172.169496056
Net income: 7190509.290201845
Capital expenditures: 12472877.957492314
Operating cash flow: 6873225.504611683
Depreciation & amortization: 11787642.02646705
Net tangible assets: 111581118.83438043
Owner earnings: 6505273.35917658
Return on net tangible assets (%): 5.830084361165387
Capex to operating income (%): 123.46728751223135
Buffett classification: The Gruesome
Stock price: 13.489573586418928
P/E ratio: 6.498073316633266
Shares outstanding: 3463746
Book value: 114155179.78879827
P/B ratio: 0.40930649522965545
Market cap (USD): 46724456.55166422
Debt to equity: 0.8170614367837561
Current ratio: 1.4856056179599284
Quick ratio: 1.3432671991800393
Effective tax rate (%): 31.45152555072872
Interest coverage ratio: 12.606545618322393
COGS to revenue (%): 78.52330206381842
Free cash flow (dilution-adjusted): -5599652.452880631
Buyback yield (%): 0.002775030882918676
Retained earnings: 16981392.861916855
Inventory turnover: 9.998728578063023
Receivables turnover: 1.8628569166259288
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.701863999320674
FCF margin (%): -4.553916282666762
Revenue growth (%): 8.417598569778841
Rule of 40 score: 3.863682287112079
Financial ratios for 9761.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 111581118.83438043
Buffett classification: The Gruesome
Stock price: 13.489573586418928
Shares outstanding: 3463746
Book value: 114155179.78879827
P/B ratio: 0.40930649522965545
Market cap (USD): 46724456.55166422
Debt to equity: 0.8170614367837561
Current ratio: 1.4856056179599284
Quick ratio: 1.3432671991800393
Buyback yield (%): 0
Retained earnings: 16981392.861916855
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9761.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.833863825076113
Shares outstanding: 3463746
Market cap (USD): 47916990.48865209
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9761.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 114238654.10497981
Buffett classification: The Gruesome
Stock price: 15.190444145356665
Shares outstanding: 3463746
Book value: 116702604.30686405
P/B ratio: 0.4508540358564036
Market cap (USD): 52615840.146702565
Debt to equity: 0.9100103004225522
Current ratio: 1.2593007591979755
Quick ratio: 1.1562849912400233
Buyback yield (%): 0
Retained earnings: 19201897.711978465
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEHR — annual report dated 2021-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.25
Shares outstanding: 32480000
Market cap (USD): 73080000
Buyback yield (%): 0.027367268746579094
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEHR — annual report dated 2022-05-31
Total revenue: 50829000
Gross profit: 23665000
Operating income: 7800000
Net income: 9450000
Capital expenditures: 416000
Operating cash flow: 1508000
Depreciation & amortization: 1045000
Net tangible assets: 50989000
Owner earnings: 10079000
Return on net tangible assets (%): 19.767008570475987
Capex to operating income (%): 5.333333333333334
Buffett classification: The Great
Stock price: 8.38
P/E ratio: 28.802370370370376
Shares outstanding: 32480000
Book value: 50989000
P/B ratio: 5.338061150444214
Market cap (USD): 272182400
Debt to equity: 0.019729745631410698
Current ratio: 5.448247684764845
Quick ratio: 4.081714181950245
Effective tax rate (%): 0.9537784299339692
COGS to revenue (%): 53.44193275492337
R&D to revenue (%): 11.446221645123847
SG&A to revenue (%): 19.766275157882312
Free cash flow (dilution-adjusted): -1914000
Buyback yield (%): 0.15761489354197772
Retained earnings: -66863000
Inventory turnover: 1.804797023453591
Receivables turnover: 3.9527957072867252
Capitalized R&D asset: 5818000
ROCI (R&D-adjusted, %): 20.44155056127331
FCF margin (%): -3.765566900784985
Rule of 40 score: -3.765566900784985
Financial ratios for AEHR — annual report dated 2023-05-31
Total revenue: 64961000
Gross profit: 32746000
Operating income: 13375000
Net income: 14557000
Capital expenditures: 1362000
Operating cash flow: 10011000
Depreciation & amortization: 1099000
Net tangible assets: 75600000
Owner earnings: 14294000
Return on net tangible assets (%): 18.907407407407405
Capex to operating income (%): 10.183177570093457
Buffett classification: The Great
Stock price: 33.02
P/E ratio: 73.67518032561655
Shares outstanding: 32480000
Book value: 75600000
P/B ratio: 14.186370370370373
Market cap (USD): 1072489600.0000001
Debt to equity: 0.08333333333333333
Current ratio: 5.459283787098356
Quick ratio: 3.993254844248222
Effective tax rate (%): 0.4104809468427174
COGS to revenue (%): 49.59129323748095
R&D to revenue (%): 10.981973799664415
SG&A to revenue (%): 18.837456319945815
Free cash flow (dilution-adjusted): 5901000
Buyback yield (%): 0.19207645463415216
Retained earnings: -52306000
Inventory turnover: 1.3474569181863811
Receivables turnover: 3.914728215017476
Capitalized R&D asset: 11032060
ROCI (R&D-adjusted, %): 17.435317395281672
Rosenberg metric: 1.5608456514266071
FCF margin (%): 9.083911885592894
Revenue growth (%): 27.803025831710244
Rule of 40 score: 36.88693771730314
Financial ratios for AEHR — annual report dated 2024-05-31
Total revenue: 66218000
Gross profit: 32543000
Operating income: 10078000
Net income: 33156000
Capital expenditures: 749000
Operating cash flow: 1756000
Depreciation & amortization: 1363000
Net tangible assets: 111593000
Owner earnings: 33770000
Return on net tangible assets (%): 30.261754769564398
Capex to operating income (%): 7.432030164715221
Buffett classification: The Great
Stock price: 11.51
P/E ratio: 11.275328748944386
Shares outstanding: 32480000
Book value: 111593000
P/B ratio: 3.3500739293683295
Market cap (USD): 373844800
Debt to equity: 0.05553215703493947
Current ratio: 9.311762466692045
Quick ratio: 5.745907879710697
Effective tax rate (%): -166.1422379194092
COGS to revenue (%): 50.85475248421879
R&D to revenue (%): 13.167114681808572
SG&A to revenue (%): 20.758706091999155
Free cash flow (dilution-adjusted): -1511000
Buyback yield (%): 0.019259329004977465
Retained earnings: -19150000
Inventory turnover: 0.8987189751801441
Receivables turnover: 6.759697835851368
Capitalized R&D asset: 15418720
ROCI (R&D-adjusted, %): 8.713368716838001
Rosenberg metric: -0.028455284552845527
FCF margin (%): -2.2818568969162465
Revenue growth (%): 1.9350071581410384
Rule of 40 score: -0.3468497387752081
Financial ratios for AEHR — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.21
Shares outstanding: 32480000
Market cap (USD): 494020800
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEHR — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.89
Shares outstanding: 32480000
Market cap (USD): 386187200
Buyback yield (%): 0.04686846172011915
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEHR — quarterly report dated 2025-02-28
Total revenue: 18307000
Gross profit: 7183000
Operating income: -1119000
Net income: -643000
Capital expenditures: 1656000
Operating cash flow: -1605000
Depreciation & amortization: 909000
Net tangible assets: 102321000
Owner earnings: -1390000
Return on net tangible assets (%): -1.358469913312028
Buffett classification: The Gruesome
Stock price: 9.64
Shares outstanding: 32480000
Book value: 124210000
P/B ratio: 2.5207889863940105
Market cap (USD): 313107200
Debt to equity: 0.05184767732066661
Current ratio: 5.708354083665339
Quick ratio: 3.073331673306773
COGS to revenue (%): 60.76364232260884
R&D to revenue (%): 17.151909105806524
SG&A to revenue (%): 28.196864587316327
Free cash flow (dilution-adjusted): -5057000
Buyback yield (%): 0.05653015963861578
Retained earnings: -20161000
Inventory turnover: 0.26279855418271164
Receivables turnover: 1.5267283796180469
Capitalized R&D asset: 3140000
ROCI (R&D-adjusted, %): 0.7343317028808012
FCF margin (%): -27.623313486644452
Rule of 40 score: -27.623313486644452
Financial ratios for AEHR — quarterly report dated 2025-05-31
Total revenue: 14089000
Gross profit: 4272000
Operating income: -2340000
Net income: -2899000
Capital expenditures: 2818000
Operating cash flow: -2302000
Depreciation & amortization: 1020000
Net tangible assets: 101371000
Owner earnings: -4697000
Return on net tangible assets (%): -4.633475056968956
Buffett classification: The Gruesome
Stock price: 9.54
Shares outstanding: 32480000
Book value: 122871000
P/B ratio: 2.521825329003589
Market cap (USD): 309859200
Debt to equity: 0.08814122128085553
Current ratio: 5.6770686788591895
Quick ratio: 2.9914950760966876
COGS to revenue (%): 69.67847256725105
R&D to revenue (%): 19.06451841862446
SG&A to revenue (%): 27.865710838242602
Free cash flow (dilution-adjusted): -6541000
Buyback yield (%): 0
Retained earnings: -23060000
Inventory turnover: 0.23375479200895302
Receivables turnover: 0.9928123458530054
Capitalized R&D asset: 4789800
ROCI (R&D-adjusted, %): -1.1593798625306735
Rosenberg metric: -0.9270700636942675
FCF margin (%): -46.4262900134857
Revenue growth (%): -23.04036707270443
Rule of 40 score: -69.46665708619012
Financial ratios for AEHR — annual report dated 2025-05-31
Total revenue: 58968000
Gross profit: 23933000
Operating income: -4813000
Net income: -3910000
Capital expenditures: 4992000
Operating cash flow: -7400000
Depreciation & amortization: 3388000
Net tangible assets: 101371000
Owner earnings: -5514000
Return on net tangible assets (%): -5.439425476714248
Buffett classification: The Gruesome
Stock price: 9.54
Shares outstanding: 32480000
Book value: 122871000
P/B ratio: 2.521825329003589
Market cap (USD): 309859200
Debt to equity: 0.08814122128085553
Current ratio: 5.6770686788591895
Quick ratio: 2.9914950760966876
COGS to revenue (%): 59.413580246913575
R&D to revenue (%): 17.743521910188576
SG&A to revenue (%): 31.004951838285173
Free cash flow (dilution-adjusted): -17554000
Buyback yield (%): 0
Retained earnings: -23060000
Inventory turnover: 0.8342262542562564
Receivables turnover: 4.155309703333098
Capitalized R&D asset: 18658950
ROCI (R&D-adjusted, %): -2.060332365531471
Rosenberg metric: -0.987498566349352
FCF margin (%): -29.768688102021436
Revenue growth (%): -10.94868464767888
Rule of 40 score: -40.71737274970032
Financial ratios for AEHR — quarterly report dated 2025-08-31
Total revenue: 10969000
Gross profit: 3719000
Operating income: -3847000
Net income: -2084000
Capital expenditures: 1391000
Operating cash flow: -282000
Depreciation & amortization: 922000
Net tangible assets: 101236000
Owner earnings: -2553000
Return on net tangible assets (%): -2.521830178987712
Buffett classification: The Gruesome
Stock price: 24.95
Shares outstanding: 32480000
Book value: 122394000
P/B ratio: 6.621043515204994
Market cap (USD): 810376000
Debt to equity: 0.08672810758697322
Current ratio: 7.055485603962058
Quick ratio: 3.543188113825233
COGS to revenue (%): 66.09535964992251
R&D to revenue (%): 25.97319719208679
SG&A to revenue (%): 43.003008478439234
Free cash flow (dilution-adjusted): -3344000
Buyback yield (%): 0.04047503874744563
Retained earnings: -25144000
Inventory turnover: 0.17327087615314757
Receivables turnover: 0.8402144772117962
Capitalized R&D asset: 5684820
ROCI (R&D-adjusted, %): -2.821383207477253
Rosenberg metric: -0.20588235294117646
FCF margin (%): -30.48591485094357
Revenue growth (%): -22.144935765490807
Rule of 40 score: -52.63085061643437
Financial ratios for AEHR — quarterly report dated 2025-11-30
Total revenue: 9884000
Gross profit: 2545000
Operating income: -4861000
Net income: -3230000
Capital expenditures: 467000
Operating cash flow: -1171000
Depreciation & amortization: 871000
Net tangible assets: 109914000
Owner earnings: -2826000
Return on net tangible assets (%): -2.5711010426333316
Buffett classification: The Gruesome
Stock price: 22.97
Shares outstanding: 32480000
Book value: 130776000
P/B ratio: 5.704912216308802
Market cap (USD): 746065600
Debt to equity: 0.07771303603107604
Current ratio: 10.61878386514148
Quick ratio: 5.474533413606261
COGS to revenue (%): 74.25131525698097
R&D to revenue (%): 30.068798057466612
SG&A to revenue (%): 44.860380412788345
Free cash flow (dilution-adjusted): -3479000
Buyback yield (%): 0.0658119071566897
Retained earnings: -28374000
Inventory turnover: 0.17178100788802284
Receivables turnover: 0.9612915775141023
Capitalized R&D asset: 5767210
ROCI (R&D-adjusted, %): -3.2317299242344695
Rosenberg metric: -0.4120744120744121
FCF margin (%): -35.19830028328612
Revenue growth (%): -9.891512444160817
Rule of 40 score: -45.08981272744694
Financial ratios for AIN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 83.65
Shares outstanding: 28354963
Market cap (USD): 2371892654.9500003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIN — annual report dated 2022-12-31
Total revenue: 1034887000
Gross profit: 389782000
Operating income: 181128000
Net income: 96508000
Capital expenditures: 93675000
Operating cash flow: 128214000
Depreciation & amortization: 69049000
Net tangible assets: 651021000
Owner earnings: 71882000
Return on net tangible assets (%): 11.041425699017388
Capex to operating income (%): 51.71756989532265
Buffett classification: The Good
Stock price: 94.16
P/E ratio: 27.66509839681684
Shares outstanding: 28354963
Book value: 867543000
P/B ratio: 3.0775458001274862
Market cap (USD): 2669903316.08
Debt to equity: 0.5707140741150583
Current ratio: 3.967702398303962
Quick ratio: 3.309683128584679
Effective tax rate (%): 26.87679951507804
Interest coverage ratio: 10.155761143818335
COGS to revenue (%): 62.33579125063896
R&D to revenue (%): 3.859455186894801
SG&A to revenue (%): 16.30255283910224
Free cash flow (dilution-adjusted): 27339000
Buyback yield (%): 3.17539588379086
Retained earnings: 931318000
Inventory turnover: 4.639374325782093
Receivables turnover: 2.9016797934114864
Capitalized R&D asset: 39941000
ROCI (R&D-adjusted, %): 14.124560353892454
FCF margin (%): 2.641737696965949
Rule of 40 score: 2.641737696965949
Financial ratios for AIN — annual report dated 2023-12-31
Total revenue: 1147909000
Gross profit: 423718000
Operating income: 168176000
Net income: 111610000
Capital expenditures: 83560000
Operating cash flow: 148056000
Depreciation & amortization: 76733000
Net tangible assets: 736541000
Owner earnings: 104783000
Return on net tangible assets (%): 14.226363501828141
Capex to operating income (%): 49.68604319284559
Buffett classification: The Good
Stock price: 94.85
P/E ratio: 24.097018551653075
Shares outstanding: 28354963
Book value: 967320000
P/B ratio: 2.780329405522474
Market cap (USD): 2689468240.5499997
Debt to equity: 0.5322509614191787
Current ratio: 3.530511221293314
Quick ratio: 2.8486402148955077
Effective tax rate (%): 30.441990327566437
Interest coverage ratio: 8.339167947637229
COGS to revenue (%): 63.08784058666671
R&D to revenue (%): 3.539217829984781
SG&A to revenue (%): 18.72230290031701
Free cash flow (dilution-adjusted): 56691000
Buyback yield (%): 0
Retained earnings: 1010942000
Inventory turnover: 4.270825101582266
Receivables turnover: 2.385984348530986
Capitalized R&D asset: 67387470
ROCI (R&D-adjusted, %): 11.002269322735875
Rosenberg metric: 0.8496532385268271
FCF margin (%): 4.938631895036976
Revenue growth (%): 10.921192362064652
Rule of 40 score: 15.859824257101629
Financial ratios for AIN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 86.54
Shares outstanding: 28354963
Market cap (USD): 2453838498.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIN — annual report dated 2024-12-31
Total revenue: 1230615000
Gross profit: 401776000
Operating income: 144797000
Net income: 88055000
Capital expenditures: 80249000
Operating cash flow: 218441000
Depreciation & amortization: 89294000
Net tangible assets: 729150000
Owner earnings: 97100000
Return on net tangible assets (%): 13.316875814304327
Capex to operating income (%): 55.421728350725495
Buffett classification: The Good
Stock price: 78.15
P/E ratio: 25.165412054397823
Shares outstanding: 28354963
Book value: 948947000
P/B ratio: 2.3351571356988323
Market cap (USD): 2215940358.4500003
Debt to equity: 0.4080312177603175
Current ratio: 3.2279229212867655
Quick ratio: 2.5836344680738272
Effective tax rate (%): 24.796522303546876
Interest coverage ratio: 8.715885150183592
COGS to revenue (%): 67.35160874847129
R&D to revenue (%): 3.7458506519098176
SG&A to revenue (%): 17.13630989383357
Free cash flow (dilution-adjusted): 132519000
Buyback yield (%): 0.6396832814541583
Retained earnings: 1065763000
Inventory turnover: 5.683012787548424
Receivables turnover: 2.8458000333000335
Capitalized R&D asset: 86497620
ROCI (R&D-adjusted, %): 9.85350025162804
Rosenberg metric: -0.5400841804711153
FCF margin (%): 10.768518179934423
Revenue growth (%): 7.204926522921242
Rule of 40 score: 17.973444702855666
Financial ratios for AIN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 78.15
Shares outstanding: 28354963
Market cap (USD): 2215940358.4500003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIN — quarterly report dated 2025-03-31
Total revenue: 288774000
Gross profit: 96486000
Operating income: 29957000
Net income: 17355000
Capital expenditures: 15597000
Operating cash flow: 2119000
Depreciation & amortization: 21291000
Net tangible assets: 683575000
Owner earnings: 23049000
Return on net tangible assets (%): 3.3718319131039025
Capex to operating income (%): 52.06462596388156
Buffett classification: The Good
Stock price: 67.72
P/E ratio: 27.660589086142323
Shares outstanding: 28354963
Book value: 905168000
P/B ratio: 2.1213720484595124
Market cap (USD): 1920198094.36
Debt to equity: 0.46005713856433283
Current ratio: 3.6952822520525017
Quick ratio: 2.9205404079512496
Effective tax rate (%): 26.565079365079363
COGS to revenue (%): 66.58771219015563
R&D to revenue (%): 4.119484441120045
SG&A to revenue (%): 18.91894699661327
Free cash flow (dilution-adjusted): -16129000
Buyback yield (%): 3.601347184080433
Retained earnings: 1074863000
Inventory turnover: 1.1937274183335196
Receivables turnover: 0.6446970677930532
Capitalized R&D asset: 11896000
ROCI (R&D-adjusted, %): 2.5392942396001934
FCF margin (%): -5.585336630029019
Rule of 40 score: -5.585336630029019
Financial ratios for AIN — quarterly report dated 2025-06-30
Total revenue: 311399000
Gross profit: 97507000
Operating income: 26453000
Net income: 9332000
Capital expenditures: 13929000
Operating cash flow: 32714000
Depreciation & amortization: 21751000
Net tangible assets: 666878000
Owner earnings: 17154000
Return on net tangible assets (%): 2.5722845857863055
Capex to operating income (%): 52.65565342305221
Buffett classification: The Good
Stock price: 69.07
P/E ratio: 73.38694099786412
Shares outstanding: 28354963
Book value: 894109000
P/B ratio: 2.1904234208692674
Market cap (USD): 1958477294.4099998
Debt to equity: 0.4973509941181668
Current ratio: 3.5110435672806006
Quick ratio: 2.777846730868537
Effective tax rate (%): 31.311644339761518
COGS to revenue (%): 68.68743958715345
R&D to revenue (%): 4.0308414606341065
SG&A to revenue (%): 18.78682975860552
Free cash flow (dilution-adjusted): 16777000
Buyback yield (%): 2.6191266115981624
Retained earnings: 1075934000
Inventory turnover: 1.3214466644425498
Receivables turnover: 0.6677610205582706
Capitalized R&D asset: 20522320
ROCI (R&D-adjusted, %): 2.0256956961659625
Rosenberg metric: 0.08582716879623403
FCF margin (%): 5.387621668663034
Revenue growth (%): 7.834846627466462
Rule of 40 score: 13.222468296129495
Financial ratios for AIN — quarterly report dated 2025-09-30
Total revenue: 261434000
Gross profit: -49938000
Operating income: -113310000
Net income: -97638000
Capital expenditures: 18033000
Operating cash flow: 43939000
Depreciation & amortization: 22438000
Net tangible assets: 518909000
Owner earnings: -93233000
Return on net tangible assets (%): -17.967119475669143
Buffett classification: The Gruesome
Stock price: 52.72
Shares outstanding: 28354963
Book value: 745007000
P/B ratio: 2.0065229579856294
Market cap (USD): 1494873649.36
Debt to equity: 0.6451362201965888
Current ratio: 2.340549065715947
Quick ratio: 1.835909251814205
Interest coverage ratio: -19.214855011022554
COGS to revenue (%): 119.10157056848001
R&D to revenue (%): 4.38619307358645
SG&A to revenue (%): 19.853959316691785
Free cash flow (dilution-adjusted): 19433000
Buyback yield (%): 3.379282257174539
Retained earnings: 970435000
Inventory turnover: 1.9501703577512777
Receivables turnover: 0.6054530001227423
Capitalized R&D asset: 23802520
ROCI (R&D-adjusted, %): -8.077665121093201
Rosenberg metric: -11.746733588272786
FCF margin (%): 7.433233626842721
Revenue growth (%): -16.045330909861626
Rule of 40 score: -8.612097283018905
Financial ratios for AIN — quarterly report dated 2025-12-31
Total revenue: 321206000
Gross profit: 99865000
Operating income: 33658000
Net income: 13998000
Capital expenditures: 22271000
Operating cash flow: 73702000
Depreciation & amortization: 22434000
Net tangible assets: 542274000
Owner earnings: 14161000
Return on net tangible assets (%): 2.6114104677709054
Capex to operating income (%): 66.16851862855785
Buffett classification: The Good
Stock price: 50.42
P/E ratio: 25.53324107836834
Shares outstanding: 28354963
Book value: 732102000
P/B ratio: 1.9528115405503605
Market cap (USD): 1429657234.46
Debt to equity: 0.6383809906269892
Current ratio: 2.1000255484436927
Quick ratio: 1.825122033384807
Effective tax rate (%): 39.29485233531376
Interest coverage ratio: 3.0426685951907433
COGS to revenue (%): 68.90936034818776
R&D to revenue (%): 3.7670529193103492
SG&A to revenue (%): 16.844953083068187
Free cash flow (dilution-adjusted): 50828000
Buyback yield (%): 1.0525599869176911
Retained earnings: 976373000
Inventory turnover: 1.8204031614701988
Receivables turnover: 0.8773171857545142
Capitalized R&D asset: 23925050
ROCI (R&D-adjusted, %): 2.5930456517664657
Rosenberg metric: 13.06383535362344
FCF margin (%): 15.824112874603838
Revenue growth (%): 22.863131803820465
Rule of 40 score: 38.68724467842431
Financial ratios for AIN — annual report dated 2025-12-31
Total revenue: 1182813000
Gross profit: 243920000
Operating income: -22421000
Net income: -56959000
Capital expenditures: 69830000
Operating cash flow: 152474000
Depreciation & amortization: 87914000
Net tangible assets: 542274000
Owner earnings: -38875000
Return on net tangible assets (%): -7.168885102365224
Buffett classification: The Gruesome
Stock price: 50.42
Shares outstanding: 28354963
Book value: 732102000
P/B ratio: 1.9528115405503605
Market cap (USD): 1429657234.46
Debt to equity: 0.6383809906269892
Current ratio: 2.1000255484436927
Quick ratio: 1.825122033384807
Interest coverage ratio: -0.8702453035242975
COGS to revenue (%): 79.3779743712658
R&D to revenue (%): 4.059390622186262
SG&A to revenue (%): 18.458200915952055
Free cash flow (dilution-adjusted): 70909000
Buyback yield (%): 13.010950843071075
Retained earnings: 976373000
Inventory turnover: 7.721858062818183
Receivables turnover: 3.230643800034415
Capitalized R&D asset: 92306900
ROCI (R&D-adjusted, %): -1.4114658605211048
Rosenberg metric: -3.424431090960366
FCF margin (%): 5.994945946654289
Revenue growth (%): -3.884399263782743
Rule of 40 score: 2.110546682871546
Financial ratios for AZK.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.4772727272727275
Shares outstanding: 24388717
Market cap (USD): 109194937.47727273
Buyback yield (%): 0
Capitalized R&D asset: 1138636.3636363635
Rule of 40 score: 0
Financial ratios for AZK.MC — annual report dated 2022-12-31
Total revenue: 181745744.68085107
Gross profit: 115754255.31914894
Operating income: 22328723.40425532
Net income: 15975531.914893618
Capital expenditures: 5408510.638297873
Operating cash flow: 20400000
Depreciation & amortization: 7720212.765957448
Net tangible assets: 19361702.127659574
Owner earnings: 18287234.042553194
Return on net tangible assets (%): 94.45054945054946
Capex to operating income (%): 24.222211634665776
Buffett classification: The Great
Stock price: 5.563829787234043
P/E ratio: 8.493906233601919
Shares outstanding: 24388717
Book value: 109396808.51063831
P/B ratio: 1.240389660031313
Market cap (USD): 135694670.1170213
Debt to equity: 0.4502737448095456
Current ratio: 1.5699675812974163
Quick ratio: 1.039320209886033
Effective tax rate (%): 24.148903929689872
Interest coverage ratio: 21.795430944963652
COGS to revenue (%): 36.30978512183843
R&D to revenue (%): 0.7334304997044035
SG&A to revenue (%): 3.68237132772578
Free cash flow (dilution-adjusted): 14991489.36170213
Buyback yield (%): 0
Retained earnings: 15864893.617021278
Inventory turnover: 1.9534561486380095
Receivables turnover: 4.626326906412479
Capitalized R&D asset: 2095865.087040619
ROCI (R&D-adjusted, %): 14.147957368815058
FCF margin (%): 8.24860542843931
Rule of 40 score: 8.24860542843931
Financial ratios for AZK.MC — annual report dated 2023-12-31
Total revenue: 213854444.44444445
Gross profit: 135455555.55555555
Operating income: 25452222.22222222
Net income: 19440000
Capital expenditures: 441111.1111111111
Operating cash flow: 17631111.111111112
Depreciation & amortization: 9871111.11111111
Net tangible assets: 36366666.666666664
Owner earnings: 28870000
Return on net tangible assets (%): 79.3858845096242
Capex to operating income (%): 1.7330946872135156
Buffett classification: The Great
Stock price: 6.433333333333334
P/E ratio: 8.071026030521264
Shares outstanding: 24388717
Book value: 128947777.77777776
P/B ratio: 1.2167774329832062
Market cap (USD): 156900746.03333333
Debt to equity: 0.37074440126493935
Current ratio: 1.6291331688291013
Quick ratio: 1.0262198519461911
Effective tax rate (%): 23.64826532838752
Interest coverage ratio: 8.102935974531304
COGS to revenue (%): 36.659929651008724
R&D to revenue (%): 0.8011679802981259
SG&A to revenue (%): 3.2181805901210065
Free cash flow (dilution-adjusted): 12122222.222222222
Buyback yield (%): 0
Retained earnings: 19261111.111111112
Inventory turnover: 1.8630914659907054
Receivables turnover: 5.231273102848445
Capitalized R&D asset: 2982179.0780141847
ROCI (R&D-adjusted, %): 14.986767441986123
Rosenberg metric: 14.779906003369682
FCF margin (%): 5.6684453080755866
Revenue growth (%): 17.666823407599917
Rule of 40 score: 23.335268715675504
Financial ratios for AZK.MC — annual report dated 2024-12-31
Total revenue: 207342708.33333334
Gross profit: 134291666.6666667
Operating income: 26817708.333333336
Net income: 19537500
Capital expenditures: 3926041.666666667
Operating cash flow: 38764583.333333336
Depreciation & amortization: 9611458.333333334
Net tangible assets: 47953125
Owner earnings: 25222916.666666668
Return on net tangible assets (%): 52.59910937330292
Capex to operating income (%): 14.639735871042921
Buffett classification: The Great
Stock price: 6.166666666666667
P/E ratio: 7.697867596502453
Shares outstanding: 24388717
Book value: 131798958.33333334
P/B ratio: 1.1411098393228323
Market cap (USD): 150397088.1666667
Debt to equity: 0.22736649094659636
Current ratio: 1.7730907135173897
Quick ratio: 1.240301183219792
Effective tax rate (%): 24.0463270430064
Interest coverage ratio: 13.075165058405283
COGS to revenue (%): 35.23202829454054
R&D to revenue (%): 1.0977196569688872
SG&A to revenue (%): 3.3132545252676477
Free cash flow (dilution-adjusted): 34818750
Buyback yield (%): 0
Retained earnings: 19369791.666666668
Inventory turnover: 2.3597361956997207
Receivables turnover: 5.9796022590723386
Capitalized R&D asset: 3863857.9787234045
ROCI (R&D-adjusted, %): 16.756729978018523
Rosenberg metric: -0.6793125810635403
FCF margin (%): 16.79285000175836
Revenue growth (%): -3.0449384056653246
Rule of 40 score: 13.747911596093036
Financial ratios for AZK.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 47953125
Buffett classification: The Gruesome
Stock price: 6.166666666666667
Shares outstanding: 24388717
Book value: 131798958.33333334
P/B ratio: 1.1411098393228323
Market cap (USD): 150397088.1666667
Debt to equity: 0.22736649094659636
Current ratio: 1.7730907135173897
Quick ratio: 1.240301183219792
Buyback yield (%): 0
Retained earnings: 19369791.666666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZK.MC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 45898823.52941176
Buffett classification: The Gruesome
Stock price: 10.964705882352941
Shares outstanding: 24388717
Book value: 147531764.70588237
P/B ratio: 1.812593439020111
Market cap (USD): 267415108.7529412
Debt to equity: 0.1637453948102901
Current ratio: 1.6494741100323624
Quick ratio: 1.1076207368683095
Buyback yield (%): 0
Retained earnings: 10711764.705882354
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBC.AX — annual report dated 2021-06-30
Total revenue: 28539849.62406015
Net income: 4254887.218045113
Capital expenditures: 18796.992481203008
Depreciation & amortization: 1730075.1879699246
Net tangible assets: 63372180.45112782
Owner earnings: 5966165.413533835
Return on net tangible assets (%): 9.414486563445452
Buffett classification: The Gruesome
Stock price: 0.37593984962406013
P/E ratio: 10.494789715497438
Shares outstanding: 118780030
Book value: 96221052.63157892
P/B ratio: 0.46407875818525646
Market cap (USD): 44654146.61654135
Debt to equity: 0.4786753559316737
Effective tax rate (%): 29.447699788056354
COGS to revenue (%): 0
SG&A to revenue (%): 60.25080351967964
Free cash flow (dilution-adjusted): -32439849.62406015
Buyback yield (%): 1.2880953136651
Retained earnings: 7527819.54887218
Receivables turnover: 0.07144188077460932
Capitalized R&D asset: 0
FCF margin (%): -113.6651035354866
Rule of 40 score: -113.6651035354866